Conexeu Sciences (CNXU) director discloses 422,148 Common Stock shares on Form 3

Rhea-AI Filing Summary

Conexeu Sciences Inc. director Lorenc Zbigniew Paul filed an initial Form 3 reporting his ownership in the company. The filing shows that he directly holds 422,148 shares of Common Stock following the reported position. The entry reflects holdings only, with no buy or sell transaction reported.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Lorenc Zbigniew Paul

Role null

Type	Security	Shares	Price	Value
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 422,148 shares (Direct, null)

Footnotes (1)

Key Figures

Director share holdings: 422,148 shares

1 metrics

Director share holdings 422,148 shares Total Common Stock directly owned following reported position

Key Terms

Common Stock, Form 3, direct ownership

3 terms

Common Stock financial

"security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 3 regulatory

"INSIDER FILING DATA (Form 3)"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

direct ownership financial

"ownership_type: "direct""

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Lorenc Zbigniew Paul

(Last) (First) (Middle)

50 WEST LIBERTY STREET, SUITE 880

(Street)

RENO NEVADA 89501

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
05/11/2026

3. Issuer Name and Ticker or Trading Symbol
Conexeu Sciences Inc. [ CNXU ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	422,148	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Z. Paul Lorenc	05/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Lorenc Zbigniew Paul’s Form 3 for CNXU report?

The Form 3 reports Lorenc Zbigniew Paul’s existing ownership in Conexeu Sciences. It shows he directly holds 422,148 shares of Common Stock, serving as an initial statement of beneficial ownership as he becomes a director of the company.

How many Conexeu Sciences (CNXU) shares does Lorenc Zbigniew Paul hold?

He is reported to hold 422,148 shares of Conexeu Sciences Common Stock. This figure represents his direct ownership following the reported position and is disclosed as part of his initial beneficial ownership statement on Form 3.

Does the CNXU Form 3 show any recent insider buying or selling?

The Form 3 does not show any insider buying or selling activity. It records only a holding entry for 422,148 shares of Common Stock, indicating existing ownership rather than a new purchase or sale transaction.

What is the ownership type reported for CNXU shares on this Form 3?

The ownership type is reported as direct. This means the 422,148 shares of Conexeu Sciences Common Stock are held directly by Lorenc Zbigniew Paul, rather than through an intermediate entity or indirect arrangement.

Why is a Form 3 filing important for Conexeu Sciences (CNXU) investors?

A Form 3 shows how many shares an insider owns when they first become a reporting person. For Conexeu Sciences, it reveals that director Lorenc Zbigniew Paul holds 422,148 common shares, giving investors visibility into his initial ownership stake.